<DOC>
	<DOCNO>NCT00778622</DOCNO>
	<brief_summary>The purpose study investigate effect baseline body mass index ( BMI ) response Glucophage XR monotherapy glycemic control Chinese patient newly diagnose type 2 diabetes</brief_summary>
	<brief_title>Body Weight Effects Glucophage 's Efficacy Chinese Diagnosed T2DM Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Signed Written Informed Consent Age≥ 17 &lt; 80 year , Newly diagnose T2DM ( define T2DM diagnose within 6 month prior enrollment ) Oral antidiabetic agent naïve ( define without receive antidiabetic medication therapy , receive antidiabetic medication ≤ 14 day receive antidiabetic medication within last 1 month prior enrollment ) HbA1c ≥ 7.0 % ≤10.0 % Women child bear potential body mass index ( BMI ) ≥35 Kg/m2 BMI &lt; 18.5 Kg/m2 Hemoglobin A1c ( HbA1c ) &gt; 10.0 % &lt; 7.0 % Active liver disease and/or significant abnormal liver function Acute chronic metabolic acidosis , include diabetic ketoacidosis , without coma Congestive heart failure define New York Heart Association ( NYHA ) class III IV /or leave ventricular ejection fraction ≤40 % Significant cardiovascular history past 6 month Severe retinopathy , persistent uncontrolled hypertension ( SBP≥180mmHg , DBP≥105mmHg ) Severe chronic gastrointestinal disease History alcohol abuse illegal drug abuse within past 12 month Diagnosed anemia Creatine kinase ≥3 X ULN Serum creatinine ≥1.5 mg/dL ( 133μmol/L ) [ male ] , ≥1.4 mg/dL ( 124 μmol/L ) [ female ] Alanine amino transferase ( ALT ) and/or aspartate amino transferase ( AST ) &gt; 1.5 X ULN and/or total bilirubin &gt; 2 X ULN Hemoglobin &lt; 12g/dL [ male ] , &lt; 11g/dL [ female ] Allergies Adverse Drug Reactions Prohibited Treatments and/or Therapies Prisoners subject involuntarily incarcerate Subjects compulsorily detain treatment either psychiatric physical ( eg , infectious disease ) illness Subjects decline participate</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>